Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

Most Recent Articles by Andrea S. Blevins Primeau, PhD, MBA

Simpler 6-MP Administration in ALL May Improve Adherence

Simpler 6-MP Administration in ALL May Improve Adherence

By

Administration restrictions on oral mercaptopurine (6-MP) are unnecessary and may impair adherence among children with ALL.

HRQOL, Not Outcomes, Differ Between United States and Chile in Osteosarcoma

HRQOL, Not Outcomes, Differ Between United States and Chile in Osteosarcoma

By

Study results indicate that although there are significant differences in HRQOL between the United States and Chile, clinical outcomes were similar.

Mutation Analyses and Outcomes With GISTs

Mutation Analyses and Outcomes With GISTs

By

Data suggest that patients whose GIST harbors a KIT exon 11 deletion should receive imatinib for 3 years.

Gaps Remain in Skin Cancer Control Research

Gaps Remain in Skin Cancer Control Research

By

A study identified gaps in behavioral research, including interventions for targets, use of technology, theory, and environmental manipulation to improve intervention.

Low Uptake of BRCA Testing in High-risk Women

Low Uptake of BRCA Testing in High-risk Women

By

Study authors attributed some of the increase in testing among low-risk women to lack of knowledge of health care providers regarding the indication of the test.

More Articles by Andrea S. Blevins Primeau, PhD, MBA

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters